Literature DB >> 21521693

Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27.

Rachel J Roth Flach1, Hui Qin, Lei Zhang, Anton M Bennett.   

Abstract

The integration of metabolic signals required for the regulation of hepatic lipid homeostasis is complex. Previously, we showed that mice lacking expression of the mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) have increased fatty acid oxidation and are protected from the development of hepatic steatosis. Here, we show that leptin receptor-deficient (db/db) mice lacking MKP-1 are also resistant to the development of hepatic steatosis. Microarray analyses of livers from db/db mice lacking MKP-1 showed suppression of peroxisome proliferator-activated receptor γ (PPARγ) target genes. We identified the fat-specific protein 27 (Fsp27), which promotes PPARγ-mediated hepatic steatosis, as repressed in livers of both db/db and high fat diet-fed mice lacking MKP-1. Hepatocytes from MKP-1-deficient mice exhibited reduced PPARγ-induced lipid droplet formation. Mechanistically, loss of MKP-1 inhibited PPARγ function by increasing MAPK-dependent phosphorylation on PPARγ at its inhibitory residue of serine 112. These results demonstrate that in addition to inhibiting hepatic fatty acid oxidation, MKP-1 promotes hepatic lipogenic gene expression through PPARγ. Hence, MKP-1 plays an important role in MAPK-mediated control of hepatic lipid homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521693      PMCID: PMC3121364          DOI: 10.1074/jbc.M110.210237

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Cidea-deficient mice have lean phenotype and are resistant to obesity.

Authors:  Zhihong Zhou; Shen Yon Toh; Zhengming Chen; Ke Guo; Chee Peng Ng; Sathivel Ponniah; Sheng-Cai Lin; Wanjin Hong; Peng Li
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

2.  Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity.

Authors:  Shamina M Rangwala; Ben Rhoades; Jennifer S Shapiro; A Sophie Rich; Jason K Kim; Gerald I Shulman; Klaus H Kaestner; Mitchell A Lazar
Journal:  Dev Cell       Date:  2003-10       Impact factor: 12.270

3.  Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.

Authors:  Songtao Yu; Kimihiko Matsusue; Papreddy Kashireddy; Wen-Qing Cao; Vaishalee Yeldandi; Anjana V Yeldandi; M Sambasiva Rao; Frank J Gonzalez; Janardan K Reddy
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

4.  Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation.

Authors:  S Hauser; G Adelmant; P Sarraf; H M Wright; E Mueller; B M Spiegelman
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

5.  Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes.

Authors:  Natasa Petrovic; Tomas B Walden; Irina G Shabalina; James A Timmons; Barbara Cannon; Jan Nedergaard
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

6.  p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response.

Authors:  P M Barger; A C Browning; A N Garner; D P Kelly
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

7.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Authors:  Kimihiko Matsusue; Martin Haluzik; Gilles Lambert; Sun-Hee Yim; Oksana Gavrilova; Jerrold M Ward; Bryan Brewer; Marc L Reitman; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  The MAP kinase phosphatase MKP-1 regulates BDNF-induced axon branching.

Authors:  Freddy Jeanneteau; Katrin Deinhardt; Goichi Miyoshi; Anton M Bennett; Moses V Chao
Journal:  Nat Neurosci       Date:  2010-10-10       Impact factor: 24.884

9.  PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.

Authors:  John S Welch; Mercedes Ricote; Taro E Akiyama; Frank J Gonzalez; Christopher K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

10.  Transcriptional regulation of the human acetoacetyl-CoA synthetase gene by PPARgamma.

Authors:  Francesca Aguiló; Nuria Camarero; Joana Relat; Pedro F Marrero; Diego Haro
Journal:  Biochem J       Date:  2010-03-29       Impact factor: 3.857

View more
  25 in total

1.  Skeletal Muscle-Specific Deletion of MKP-1 Reveals a p38 MAPK/JNK/Akt Signaling Node That Regulates Obesity-Induced Insulin Resistance.

Authors:  Ahmed Lawan; Kisuk Min; Lei Zhang; Alberto Canfran-Duque; Michael J Jurczak; Joao Paulo G Camporez; Yaohui Nie; Timothy P Gavin; Gerald I Shulman; Carlos Fernandez-Hernando; Anton M Bennett
Journal:  Diabetes       Date:  2018-01-09       Impact factor: 9.461

2.  Hepatocyte-specific Sirt6 deficiency impairs ketogenesis.

Authors:  Lei Chen; Qinhui Liu; Qin Tang; Jiangying Kuang; Hong Li; Shiyun Pu; Tong Wu; Xuping Yang; Rui Li; Jinhang Zhang; Zijing Zhang; Ya Huang; Yanping Li; Min Zou; Wei Jiang; Tao Li; Meng Gong; Lu Zhang; Hua Wang; Aijuan Qu; Wen Xie; Jinhan He
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

3.  Fasting regulates FSP27 expression in the liver.

Authors:  Vishwajeet Puri
Journal:  J Lipid Res       Date:  2013-01-18       Impact factor: 5.922

Review 4.  Mechanisms for insulin resistance: common threads and missing links.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell       Date:  2012-03-02       Impact factor: 41.582

5.  Mitogen-activated protein kinase phosphatase (Mkp)-1 protects mice against acetaminophen-induced hepatic injury.

Authors:  Lyn M Wancket; Xiaomei Meng; Lynette K Rogers; Yusen Liu
Journal:  Toxicol Pathol       Date:  2012-05-23       Impact factor: 1.902

6.  Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.

Authors:  Xu Xu; Jong-Gil Park; Jae-Seon So; Ann-Hwee Lee
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

Review 7.  Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.

Authors:  Ahmed Lawan; Anton M Bennett
Journal:  Trends Endocrinol Metab       Date:  2017-11-08       Impact factor: 12.015

Review 8.  Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.

Authors:  Lyn M Wancket; W Joshua Frazier; Yusen Liu
Journal:  Life Sci       Date:  2011-12-13       Impact factor: 5.037

Review 9.  Role of lipid droplet proteins in liver steatosis.

Authors:  Toshikatsu Okumura
Journal:  J Physiol Biochem       Date:  2011-08-17       Impact factor: 4.158

10.  Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver.

Authors:  Daisuke Aibara; Kimihiko Matsusue; Kohei Matsuo; Soichi Takiguchi; Frank J Gonzalez; Shigeru Yamano
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.